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Comparison of General Population, Patient,
and Carer Utility Values for Dementia
Health States
Donna Rowen, PhD, Brendan Mulhern, MRes, Sube Banerjee, MD,
Rhian Tait, PGDip, Caroline Watchurst, MSc, Sarah C. Smith, PhD,
Tracey A. Young, PhD, Martin Knapp, PhD, John E. Brazier, PhD
Utility values to estimate quality-adjusted life years (QA-
LYs) for use in cost-utility analyses are usually elicited
from members of the general population. Public attitudes
and understanding of dementia in particular may mean
that values elicited from the general population may differ
from patients and carers for dementia health states. This
study examines how the population impacts utility values
elicited for dementia health states using interviewer-
administered time tradeoff valuation of health states
defined by the dementia-specific preference-based meas-
ures DEMQOL-U (patient-report) and DEMQOL-Proxy-U
(carer-report). Eight DEMQOL-U states were valued by 78
members of the UK general population and 71 patients
with dementia of mild severity. Eight DEMQOL-Proxy-U
states were valued by 77 members of the UK general pop-
ulation and 71 carers of patients with dementia of mild
severity. Random-effects generalized least squares
regression estimated the impact of population, dementia
health state, and respondent sociodemographic character-
istics on elicited values, finding that values for dementia
health states differed by population and that the differ-
ence varied across dementia health states. Patients
with dementia and carers of patients with dementia gave
systematically lower values than members of the general
population that were not due to differences in the sociode-
mographic characteristics of the populations. Our results
suggest that the population used to produce dementia
health state values could impact the results of cost-utility
analyses and potentially affect resource allocation deci-
sions; yet, currently, only general population values are
available for usage. Key words: quality-adjusted life years;
health-related quality of life; preference-based measures
of health; dementia; Alzheimer’s disease; utilities. (Med
Decis Making 2015;35:68–80)
Resource allocation decisions are increasinglybeing informed by cost-utility analyses measur-
ing the benefits of treatment using the quality-
adjusted life year (QALY), which captures changes
in both quantity and health-related quality of life
(HRQL). Typically, the ‘‘quality’’ component of the
QALY is measured using an ‘‘off-the-shelf’’ patient-
reported generic preference-based measure valued
by the general population such as the EQ-5D,1
HUI2,2 HUI3,3 and SF-6D.4,5 However, the validity
and responsiveness of generic measures have been
questioned for use in some conditions including
dementia.6 Patients with dementia can exhibit im-
pairments of recall, time perception, insight, and
expressive and receptive communication. This
means that patients with more severe symptoms
may have particular difficulties in making self-
reports of their own HRQL. For these patients, proxy
reporting may be necessary. The DEMQOL system
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(self-reported DEMQOL and proxy [carer]–reported
DEMQOL-Proxy) was specifically developed and
validated in a population with dementia and can
be used together to measure the HRQL of patients
with mild, moderate, and severe dementia.7,8 DEM-
QOL-U and DEMQOL-Proxy-U are recently devel-
oped dementia-specific preference-based measures
derived from DEMQOL and DEMQOL-Proxy. These
measures were valued by members of the UK general
population and can be used to estimate QALYs for
use in cost-utility analyses.9–11
Utility values for preference-based measures can
be elicited from a number of populations including
members of the general population, patients affected
by a particular illness, carers, and health care profes-
sionals. Typically, utility values for use in economic
evaluations are elicited from the general population
in accordance with recommendations by agencies
such as the National Institute for Health and Care
Excellence (NICE)12 and the Canadian Agency for
Drugs and Technologies in Health.13 General popula-
tion values are typically recommended, as health care
is publicly funded (partly or fully, depending on
a country’s health system). Furthermore, members
of the general population, unlike patients, have no
vested interest, as they do not have prior knowledge
of their own future health states. In addition, the
practicality of undertaking general population stud-
ies rather than separate patient valuation studies
across all patient groups is an advantage. However,
members of the general population may not fully
understand the impact of hypothetical health states,
whereas patients who have experienced similar
health states may be better able to providemore accu-
rate valuations. The source of elicited utility values is
important because the general population may pro-
vide different values to other populations. This
means that the choice of whose values may affect
the values obtained and can impact the results of eco-
nomic evaluations based on such data.14
A review and meta-analysis found that patients
and the general population provide almost identical
values for hypothetical health states.15 However,
the results differed by health state description and
elicitation technique, where patients gave signifi-
cantly lower values than the general population
when values were elicited using time tradeoff
(TTO). The results also differedwhen patients valued
their own health state but the general population val-
ued a hypothetical state, where patients gave higher
values. Reasons for observed differences in general
population and patient values include the following:
1) different populations value different health states
due to differences in their understanding or interpre-
tation of the description; 2) different populations
have different scales of measurement due to
a response shift; and3) patientsmay take into account
adaptation to the health state, whereas members of
the general population typically do not consider
adaptation. In a valuation survey, all participants
have to imagine what it is like to be in a hypothetical
state; yet, members of the general population have
less to base this on than patients whomay have expe-
rienced similar health states and have a greater
understanding of what it is like to experience that
health state. This also means that the patient may
consider additional information about the experience
of the health state that is not included in the health
state description. The patient may have knowledge
of adaptation to the health state or similar states but
as a result may be unable to imagine full health or
mild health states and may have lowered their
expectations as a result. In addition, members of the
general population and patients may differ in their
sociodemographic characteristics, and this may also
affect how they value health states.
The literature examining differences between val-
ues elicited by patients and members of the general
population has mainly focused on physical health
states; yet, the relationship may differ for conditions
affecting mental health and cognition. One work
reporting on 2 studies found that people experiencing
a range of different health states gave mental health
a greater weight than physical health, whereas mem-
bers of the general public trying to imagine the same
health states gave physical health a higher weight
than mental health.16 Another article found that
patients with depression gave lower utility values
for depression health states than the general popula-
tion.17 One article found that patients with epilepsy
did not give significantly different utility values for
epilepsy health states than the general population,
with the exception of a significantly higher value
for the worst possible state.18 Public attitudes and
the understanding of dementia in particular may
mean that patient and general population values
will differ. In addition, values elicited from carers
of patients with dementia may differ from values eli-
cited from the general population, as carers have
experience of how the condition impacts the patient.
At the same time, carers may be in a better position to
value states than patients, particularly as cognitive
impairment becomes more severe.
Previous studies have been limited in a number of
ways. They usually fail to adjust for sociodemo-
graphic differences between populations. It is
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important to control for sociodemographic character-
istics of the samples19 because elicited TTO values
can vary by sociodemographic characteristics,20
meaning that some of the variation in values across
populationsmay be due to differences in the sociode-
mographic characteristics of the population. The
literature is also limited, asmost studies ask respond-
ents to value only a small number of states. This
means that it cannot be determined whether there
are systematic differences in values elicited from dif-
ferent populations across all health states and
whether the difference varies by health state severity.
Even studies that valued a large sample of health
states have not examined whether differences vary
by severity. For example, one study estimated differ-
ent value sets for patients andmembers of the general
population for the EQ-5D but, when using the data
from both populations to estimate a combined value
set, did not include interaction effects for the severity
levels of each dimension.21 However, one study
reported that values elicited using a visual analog
scale with members of the general population with
no health problems, mild health problems, and mod-
erate health problems did vary by health state
severity.19
To address these general limitations and to inves-
tigate the difference in values elicited for dementia
health states frommembers of the general population,
patients with dementia, and their carers, we com-
pleted a between-subject study comparing dementia
health state values from samples of the general popu-
lation, patients with mild dementia, and carers of
patients with mild dementia for a range of dementia
health states of differing severity. Dementia health
states were defined using DEMQOL-U and DEM-
QOL-Proxy-U.9,10 Regression analysis was used to
explore whether population, dementia health state
severity, and respondent sociodemographic charac-
teristics impact elicited utility values.
METHODS
Dementia Health State Description
Dementia health state descriptions were generated
using the DEMQOL-U and DEMQOL-Proxy-U classi-
fication systems9,10 (Table 1). DEMQOL-U was
derived from the DEMQOL patient-reported measure
of HRQL and has 5 dimensions (positive emotion,
memory, relationships, negative emotion, and
loneliness), each with 4 levels of severity. DEM-
QOL-Proxy-U was derived from the carer-reported
DEMQOL-Proxy measure of HRQL and has 4 dimen-
sions (positive emotion, memory, appearance, and
negative emotion), each with 4 levels of severity.
The classification systems of DEMQOL-U and DEM-
QOL-Proxy-U differ, as they were each derived from
a different parent measure that has different domains
and items (although some are common across both
measures). DEMQOL and DEMQOL-Proxy have dif-
ferent items because in the development studies,
items were found to work differently for people
with dementia and family carers. The final instru-
ments included those items that worked best for the
target group completing the instrument, but both
measure the HRQL of the person with dementia.
Both DEMQOL and DEMQOL-Proxy were derived
by the same research team at the same time using
the same methodology, as were the utility measures
that were derived from them. Each dementia health
state is made up of each dimension at a selected level
of severity; for example, DEMQOL-U health state
11111 ismade up of all dimensions at the lowest level
of severity, and DEMQOL-U health state 44444 is
made up of all dimensions at the highest level of
severity.
Selection of Dementia Health States
A sample of 8 dementia health states for each of the
2 measures was selected that represented the full
severity range of each classification system while
ensuring that there was a mixture of severity levels
for each dimension across the dementia health states.
For each measure, all respondents valued the same
states.
Samples
Dementia health states derived from each measure
were valued by members of the general population
in accordance with recommendations from NICE12
and also by the population that completes the
questionnaire and was involved in the initial devel-
opment of the parent measure (DEMQOL and DEM-
QOL-Proxy).7,8 This means that DEMQOL-U health
states were also valued by people with dementia
and that DEMQOL-Proxy-U health states were also
valued by carers of people with dementia. The sam-
ple size of each population for eachmeasurewas cho-
sen to ensure sufficient power for a comparison of
mean dementia health state values across the
different populations for each measure using simple
t tests. This required a total of 71 completed interviews
per population per classification system, assuming
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a power of 0.8, significance level of 0.05, standard
deviation of 0.3, and expected difference of 0.1.
General population. The sample was a subset of
155 respondents from the 600 respondents included
in the general population valuation study of DEM-
QOL-U and DEMQOL-Proxy-U.9 The sample of
respondents used here consisted of those who val-
ued the 8 DEMQOL-U and 8 DEMQOL-Proxy-U
health states also valued by patients and carers.
Interviewers systematically rotated combinations of
dementia health states in the interviews to ensure
that the subsample used here was a random sample
of the 600 and hence representative of the general
population. The sample of 600 respondents was
obtained by sampling households in urban and rural
areas in North England using the AFD Names and
Numbers version 3.1.25 database (AFD Software
Ltd, Ramsey, UK). The sample was then balanced
to the UK population according to geodemographic
profiles. Households that were sampled were first
contacted by post using a letter introducing the sur-
vey and informing them that interviewers would be
in their area. Trained and experienced interviewers
then visited sampled households to request partici-
pation in the survey and to arrange a suitable
appointment for a home interview. The interviewers
visited each sampled household at different times of
the week if there was no response.
Patients with dementia and carers. Patients with
an established clinical diagnosis of dementia of
a mild severity (defined as a Mini-Mental State
Examination [MMSE] score .18)22 and their carers
were recruited by 2 research workers (authors RT
and CW) from the clients of clinical teams from the
Mental Health of Older Adults and Dementia Ser-
vice at the South London and Maudsley NHS Foun-
dation Trust including the following: the Croydon
Memory Service, the Southwark and Lambeth Mem-
ory Service, and Community Mental Health Teams
in Croydon and Lewisham. Clinical diagnoses were
Table 1 DEMQOL-U and DEMQOL-Proxy-U Health State Classification Systems
DEMQOL-U DEMQOL-Proxy-U
Positive emotion Positive emotion
1. I feel cheerful a lot 1. I feel lively a lot
2. I feel cheerful quite a bit 2. I feel lively quite a bit
3. I feel cheerful a little 3. I feel lively a little
4. I do not feel cheerful at all 4. I do not feel lively at all
Memory Memory
1. I do not worry at all about forgetting things
that happened recently
1. I do not worry at all about forgetting what day it is
2. I worry a little about forgetting things
that happened recently
2. I worry a little about forgetting what day it is
3. I worry quite a bit about forgetting things
that happened recently
3. I worry quite a bit about forgetting what day it is
4. I worry a lot about forgetting things that happened recently 4. I worry a lot about forgetting what day it is
Relationships Appearance
1. I do not worry at all about making myself understood 1. I do not worry at all about keeping myself looking nice
2. I worry a little about making myself understood 2. I worry a little about keeping myself looking nice
3. I worry quite a bit about making myself understood 3. I worry quite a bit about keeping myself looking nice
4. I worry a lot about making myself understood 4. I worry a lot about keeping myself looking nice
Negative emotion Negative emotion
1. I do not feel frustrated at all 1. I do not feel frustrated at all
2. I feel frustrated a little 2. I feel frustrated a little
3. I feel frustrated quite a bit 3. I feel frustrated quite a bit
4. I feel frustrated a lot 4. I feel frustrated a lot
Loneliness
1. I do not feel lonely at all
2. I feel lonely a little
3. I feel lonely quite a bit
4. I feel lonely a lot
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made following a detailed multidisciplinary assess-
ment,23 and diagnostic data were obtained from
the clinical record. Letters introducing the survey
and information sheets were sent by post to all
patients referred as suitable for participation in the
study by their care coordinators. Research workers
then contacted the patients by telephone to arrange
a suitable appointment for a home interview with
the interviewers visiting as a pair. If both the patient
with dementia and their carer were participating,
interviews were conducted simultaneously in a dif-
ferent room where possible. The research workers
received the same training as the interviewers who
carried out the general population survey.
Valuation Task
The TTO technique was chosen in accordance
with the UK valuation of the EQ-5D using the Mea-
surement and Valuation of Health (MVH) protocol,
including a visual prop designed by the MVH group
(University of York)1 with an upper anchor of ‘‘full
health.’’ This determines the point at which respond-
ents are indifferent between 10 years in the dementia
health state and x years in full health. For states
regarded as worse than dead, indifference is deter-
mined between death and y years in the dementia
health state, followed by x number of years in full
health (where x 1 y = 10). This meets the reference
case recommended by NICE.12 At the start of the
interview, respondents self-completed the EQ-5D;
the patient sample completed the DEMQOL-U, and
the carer sample completed the DEMQOL-Proxy-U
to familiarize themselves with the classification sys-
tem used in the valuation task. General population
respondents then ranked 8 dementia health states
plus ‘‘full health’’ and ‘‘dead’’ in order from best to
worst. Patients with dementia and carers did not
undertake the ranking task, as it requires the consid-
eration of all 10 health states (8 dementia health states
and full health and dead) simultaneously, and given
that dementia is a condition that affects memory,
this was considered inappropriate. The same proto-
col was used for both patients with dementia and
carers for consistency and to ensure that patients
with dementia felt that they were treated the same
as their carers. The general population sample was
not informed that the survey was about dementia.
All respondents undertook a practice TTO task
using a hypothetical ‘‘practice’’ state to familiarize
themselves with the process. All respondents then
valued 8 DEMQOL-U or DEMQOL-Proxy-U health
states using TTO, and for general population
respondents, these were the dementia health states
that they had previously ranked. At the end of the
interview, respondents rated how difficult they
found the rank (where appropriate) and TTO tasks
and answered questions about sociodemographic
characteristics and health service use. Interviewers
reported whether they thought the respondent had
understood the TTO tasks (understood and per-
formed exercises easily/some problems but seemed
to understand the exercises in the end/doubtful
whether the respondent understood the exercises).
The general population survey was approved by
the ScHARR Research Ethics Committee at the Uni-
versity of Sheffield. The patient with dementia and
carer survey was approved by the London Research
Ethics Committee.
Analysis
A factorial analysis of variance, estimated using
a generalized linear model, was performed to assess
significant differences in respondent characteristics
across the different populations. Descriptive statis-
tics of dementia health state values across the differ-
ent populations are presented by measure. Simple t
tests were used to compare mean dementia health
state values across the different populations.
Regression Analysis
Regression analysis was used to examine the
impact of population and dementia health state
severity on elicited utility values while controlling
for respondent sociodemographic characteristics.
The standard model specification was
yij 5a1bhj1gpi1 uqij1 dsi1 eij ; ð1Þ
where i5 1; 2; :::;n represents individual respond-
ents and j51;2; :::;m represents the 8 DEMQOL-U
or DEMQOL-Proxy-U health states, y represents the
TTO utility value, h represents the vector of dummy
variables for the dementia health states, p represents
the dummy variable capturing the population (where
p = 1 for patients with dementia and carers), q repre-
sents the vector of interaction terms to capture the
population and dementia health state (e.g., in the
DEMQOL-U regression analysis, a dummy variable
for state 12231 valued by patients equals 1 for state
12231 valued by a patient with dementia), s repre-
sents the vector of sociodemographic characteristics,
and eij represents the error term. Random-effects and
fixed-effects generalized least squares models were
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72  MEDICAL DECISION MAKING/JANUARY 2015
estimated, as all respondents have multiple observa-
tions.24 The reference dementia health state in the
regression analysis is measure-specific full health,
health state 11111 for DEMQOL-U, and health state
1111 for DEMQOL-Proxy-U.
Three model specifications were estimated: first,
regressions were estimated using dementia health
state dummies and population as explanatory
variables; second, interaction terms capturing popu-
lation and dementia health state effects were added;
and third, sociodemographic characteristics were
added. This procedure was undertaken to determine
whether model performance was improved by
including interactions that allow for the impact of
population to vary by dementia health state in the
model specification and to determine whether popu-
lation and severity effects were important when
respondent sociodemographics were controlled for
(as some differences in values across populations
may be due to the differences in the sociodemographic
composition of the samples rather than the population
per se). A further model was estimated using a sample
that excluded respondents whose understanding of
the TTO task was doubted by the interviewers.
The performance of regression models was
assessed using within R2, between R2, overall R2,
root mean squared error of predictions, and Wald
x2. STATA version 11 (StataCorp, College Station,
TX) was used for all regression analyses, and SPSS
version 15 (SPPS Inc, Chicago, IL) was used for the
descriptive statistical analysis.
RESULTS
Samples
Recruitment of the general population sample is
summarized elsewhere,9 and recruitment of the
patient sample is also summarized in another
work.11 Patients with dementia and carers were
recruited between 7 November 2010 and 23 May
2011, during which the clinical teams referred 196
patients diagnosed with dementia. Of these, 93
patients and 73 carers agreed to be interviewed and
were assessed as suitable by the research workers.
Recruitment continued until 71 patients and 71
carers had completed the interview. During the pro-
cess, 21 partial interviews were undertaken, 19 with
patients and 2 with carers, and 3 patients were not
able to participate at the time of the arranged inter-
view. Partial interviews were interviews terminated
before the end of the TTO tasks due to respondent
fatigue, misunderstanding, or distress, and these 21
interviews are therefore excluded from the analysis.
Some patients were interviewed without carers, and
a few carers were interviewed without patients,
meaning the completed interviews contained 49
patient/carer dyads.
One general population respondent was excluded
for valuing all states identically but lower than one,
as this indicates that they could not distinguish
between the different dementia health states and
hence may have misunderstood the task. No patients
with dementia or carers were excluded on this basis.
There were significant differences between the
general population and patient samples valuing the
DEMQOL-U measure for age, employment status,
education, and interviewers reporting that it was
doubtful that the respondent understood the TTO
tasks (Table 2). As expected, the patient sample was
significantly older, with a mean (6standard devia-
tion) age of 78.4 6 7.7 years in comparison to 49.6
6 17.0 years for the general population sample. The
patient sample had a much higher proportion of
retired individuals and those for which secondary
schoolwas their highest level of education.Addition-
ally, the patient sample had a higher proportion of
respondents in which the interviewers reported that
it was doubtful that respondents understood the
TTO tasks. The EQ-5D scores of their own health
were similar between both samples. Although this
might appear surprising, the validity of using generic
preference-based measures in dementia has been
questioned, with one study finding that 48% of peo-
ple with dementia self-reported being in full health
using the EQ-5D.25 ThemeanMMSE score of patients
was 23.5 6 2.8, with a range from 19 to 30.
There were significant differences between the
general population and carer samples valuing the
DEMQOL-Proxy-U measure for age, employment sta-
tus, marital status, home ownership, and inter-
viewers reporting that it was doubtful that the
respondent understood the TTO tasks (Table 2). The
carer sample was significantly older, with a mean
age of 69.8 6 12.7 years in comparison to 50.7 6
16.2 years for the general population sample. The
carer sample had a lower proportion of employed
and unemployed individuals and students but
a higher proportion of retired individuals, married
individuals, and individuals owning their own
home. The carer sample had a higher proportion of
respondents in which the interviewers reported that
it was doubtful that they understood the TTO tasks.
The EQ-5D scores of their own health were similar
between both samples.
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Descriptive Statistics of Dementia Health State
Values
Descriptive statistics of observed TTO values for
DEMQOL-U show that TTO values elicited from
patients have significantly lower mean and lower
median values for every dementia health state than
the equivalent values elicited from the general popu-
lation (Table 3). The patient sample also has a larger
range of mean utility values (0.816 to –0.023) than
the general population sample (0.955 to 0.190). The
ordering of the dementia health states by utility value
differs for the patient and general population sam-
ples. However, for each sample, the ordering of the
dementia health states is not logically inconsistent
with the severity of the dementia health state, as for
many states, it is not possible to determine a logical
ordering because one state is not consistently better
across all dimensions.
Descriptive statistics of observed TTO values for
DEMQOL-Proxy-U show that TTO values elicited
from carers also have significantly lower mean and
median values for every dementia health state than
the equivalent values elicited from the general popu-
lation (with the exception that the difference is not
significant for the best state) (Table 4). The carer sam-
ple also has a larger range of mean utility values
(0.857–0.049) than the general population sample
(0.918–0.370). The ordering of the dementia health
states by utility value differs for the carer and general
population samples, but the ordering is logically con-
sistent for each population.
Regression Analysis
Models using a range of sociodemographic varia-
bles as explanatory variables were estimated, and
the best models (using significance of coefficients,
Table 2 Characteristics of Respondents by Measure and Population
DEMQOL-U DEMQOL-Proxy-U
General
Population
(n = 78)
Patient
Population
(n = 71)
P Value
(ANOVA)
General
Population
(n = 77)
Carer
Population
(n = 71)
P Value
(ANOVA)
Age, mean 6 standard
deviation, y
49.6 6 17.0 78.4 6 7.7 \0.001 50.7 6 16.2 69.8 6 12.7 \0.001
Age distribution,a % \0.001 \0.001
18-40 y 30.8 0.0 32.5 0.0
41-65 y 48.7 8.5 45.4 33.8
.65 y 20.5 91.5 22.1 66.2
Female, % 52.6 54.9 0.77 51.9 63.4 0.16
Married/partner, % 66.7 62.0 0.55 74.0 85.9 0.07
Employment status,a % \0.001 0.002
Employed or self-employed 53.8 2.8 45.5 29.6
Unemployed 2.6 0.0 2.6 0.0
Long-term sick 3.8 0.0 1.3 0.0
Full-time student 1.3 0.0 5.2 0.0
Retired 24.4 90.1 33.8 62.0
Own home outright or with
mortgage, %
79.5 87.3 0.20 72.7 94.4 \0.001
Secondary school is highest
level of education, %
34.6 50.7 0.05 35.1 38.0 0.71
Interviewer reported that it was
doubtful that respondent
understood TTO tasks, %
1.3 12.7 0.001 0.0 7.0 0.02
Duration of interview, mean 6
standard deviation, min
28.5 6 9.0 29.4 6 12.0 0.583 28.0 6 8.0 22.5 6 7.4 \0.001
EQ-5D score, mean 6 standard
deviation
0.87 6 0.19 0.85 6 0.14 0.79 6 0.25 0.78 6 0.19
Notes: Adapted from Mulhern and others.11 TTO = time tradeoff.
a. To adhere to statistical assumptions, categories aremerged if there are 0 observations or fewer than 5 expected observations, and x2 P values are reported.
ROWEN AND OTHERS
74  MEDICAL DECISION MAKING/JANUARY 2015
within R2, between R2, overall R2, root mean squared
error of predictions, and Wald x2) had only 1 signifi-
cant coefficient at the 5% level across all models esti-
mated (dummy variable for female for DEMQOL-U
for the model excluding respondents whose under-
standing of the TTO task was doubted by the inter-
viewers), and this had a minimal impact on model
performance. For this reason, models including soci-
odemographic characteristics are not presented here.
Models without sociodemographic characteristics
are presented in Tables 5 and 6 for DEMQOL-U
and DEMQOL-Proxy-U, respectively. Random-effects
models were reported, as the Hausman test confirmed
for bothmeasures that fixed-effectsmodelswouldpro-
duce similar estimates at reduced efficiency.
Dementia health state dummy variables were sig-
nificant at the 1% level across all models, with the
exception of state 12231 in models 2 and 3 and state
1222 in models 5 and 6. The dummy variable
representing population inmodels 1 and 4was signif-
icant at the 1% level and demonstrated that patients
and carers value states significantly lower than the
general population.
The inclusion of interaction terms in models 2 and
5 reflecting the interaction between the specific
dementia health state and the patient or carer popula-
tion improvedmodel performance asmeasured using
within and overall R2 and Wald x2 and reduced the
absolute size of the coefficient for the state dummy
variables, with the exception of DEMQOL-U state
23424 in model 2. The interaction effects had nega-
tive coefficients, meaning that patients and carers
had an additional utility decrement for each state
above the utility decrement reflected by the coeffi-
cients of the dementia health state dummy variables.
The size of the interaction coefficients varied
by dementia health state, meaning that the impact
of the population differs by state severity and
Table 3 Descriptive Statistics of Observed TTO for DEMQOL-U
Sample General Population (n = 78) Patient Population (n = 71)
Mean DifferenceHealth State Mean 6 SD Median Mean 6 SD Median
11111 0.955 6 0.153 1.000 0.816 6 0.241 0.900 0.139a
12231 0.894 6 0.160 1.000 0.633 6 0.297 0.700 0.261a
32143 0.673 60.302 0.663 0.399 6 0.398 0.500 0.274a
41212 0.611 6 0.364 0.625 0.436 6 0.347 0.500 0.175a
23424 0.566 6 0.340 0.600 0.435 6 0.327 0.500 0.131b
44221 0.544 6 0.367 0.525 0.327 6 0.439 0.475 0.217a
43442 0.403 6 0.412 0.475 0.161 6 0.455 0.225 0.241a
44444 0.190 6 0.484 0.250 –0.023 6 0.456 0.000 0.213a
Notes: Adapted from Mulhern and others.11 SD = standard deviation; TTO = time tradeoff.
a. t test is significant at the 1% level.
b. t test is significant at the 5% level.
Table 4 Descriptive Statistics of Observed TTO for DEMQOL-Proxy-U
Sample General Population (n = 77) Carer Population (n = 71)
Mean DifferenceHealth State Mean 6 SD Median Mean 6 SD Median
1111 0.918 6 0.185 1.000 0.857 6 0.211 1.000 0.061
1222 0.869 6 0.174 0.925 0.731 6 0.251 0.700 0.138a
3112 0.804 6 0.255 0.925 0.666 6 0.313 0.725 0.138a
1341 0.807 6 0.236 0.900 0.640 6 0.250 0.700 0.167a
3234 0.672 6 0.272 0.700 0.458 6 0.361 0.500 0.215a
2424 0.638 6 0.341 0.700 0.464 6 0.364 0.500 0.174a
4411 0.580 6 0.395 0.625 0.380 6 0.406 0.500 0.200a
4444 0.370 6 0.482 0.400 0.049 6 0.465 0.000 0.321a
Notes: Adapted from Mulhern and others.11 SD = standard deviation; TTO = time tradeoff.
a. t test is significant at the 1% level.
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composition. Interaction effects reflecting the inter-
action between patient valuation and dementia
health state for DEMQOL-U had larger coefficients
for all dementia health states with more severe prob-
lems in the (fourth) negative emotion dimension
(states 12231, 32143, 43442, and 44444). Interaction
effects reflecting the interaction between carer valua-
tion and dementia health state for DEMQOL-Proxy-U
had larger coefficients for all dementia health states
with more severe problems in 1 or more dimensions
(states 1341, 2424, 3234, 4411, and 4444), with
a noticeably larger coefficient for theworst state (state
4444). The exclusion of respondents whose under-
standing of the TTO task was doubted by the inter-
viewers in models 3 and 6 had no noticeable impact
on coefficients for dementia health state severity
and interaction effects.
DISCUSSION
The TTO utility values for dementia health states
differed depending upon whether the values were
elicited from patients with dementia and the carers
of patients with dementia or members of the general
population. It is striking that patients and carers
gave systematically lower utility values for every
dementia health state than members of the general
population. This is contrary to the overall findings
of a recent review and meta-analysis that found that
patient and general population preferences for hypo-
thetical health stateswere almost identical but is con-
sistent with the sensitivity analysis that found that
patient values were significantly lower than general
population values when using the TTO elicitation
technique to value hypothetical health states.15
Table 5 Regression Analysis of DEMQOL-U Health State Values across General Population and Patient
Respondents
Model 1 Model 2 Model 3
States
12231 –0.119a (–0.179 to –0.059) –0.0606 (–0.143 to 0.022) –0.0606 (–0.143 to 0.021)
32143 –0.346a (–0.406 to –0.286) –0.281a (–0.364 to –0.198) –0.281a (–0.363 to –0.199)
41212 –0.361a (–0.421 to –0.301) –0.344a (–0.426 to –0.261) –0.344a (–0.426 to –0.262)
23424 –0.385a (–0.444 to –0.325) –0.388a (–0.471 to –0.305) –0.388a (–0.470 to 0.306)
44221 –0.448a (–0.508 to –0.388) –0.411a (–0.493 to –0.328) –0.411a (–0.493 to –0.329)
43442 –0.601a (–0.661 to –0.541) –0.552a (–0.635 to –0.469) –0.552a (–0.634 to –0.470)
44444 –0.800a (–0.860 to –0.740) –0.765a (–0.847 to –0.682) –0.765a (–0.847 to –0.683)
Patient population –0.206a (–0.290 to –0.123)
Patient interaction terms
11111 3 patient –0.139b (–0.254 to –0.023) –0.119b (–0.234 to –0.003)
12231 3 patient –0.261a (–0.376 to –0.146) –0.248a (–0.363 to –0.132)
32143 3 patient –0.274a (–0.389 to –0.159) –0.249a (–0.364 to 0.133)
41212 3 patient –0.175a (–0.291 to –0.060) –0.177a (–0.291 to –0.061)
23424 3 patient –0.131b (–0.246 to 0.016) –0.138b (–0.253 to –0.022)
44221 3 patient –0.217a (–0.332 to –0.101) –0.194a (–0.310 to –0.079)
43442 3 patient –0.241a (–0.357 to –0.126) –0.224a (–0.339 to –0.108)
44444 3 patient –0.213a (–0.328 to –0.097) –0.207a (–0.322 to –0.091)
Constant 0.987a (0.917 to 1.057) 0.954a (0.875 to 1.034) 0.954a (0.878 to 1.031)
Observations 1192 1192 1120
Number of individuals 149 149 140
Within R2 0.478 0.483 0.489
Between R2 0.137 0.137 0.136
Overall R2 0.341 0.385 0.358
Root mean squared error 0.251 0.251 0.242
Wald x2 971.76 986.02 944.96
Notes: 95% confidence intervals are in parentheses. The reference state is 11111 valued by the general population. Model 1 includes as explanatory var-
iables dementia health state dummies and population. Model 2 also includes interaction terms capturing population and dementia health state effects.
Model 3 has the same specification asmodel 2 and excludes 9 respondents whose understanding of the time tradeoff task was doubted by the interviewers.
The patient population variable is a dummy variable for patients.
a. Significant at 1% level.
b. Significant at 5% level.
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Descriptive statistics of observed values and regres-
sion analysis indicated that utility values across pop-
ulations differed for different dementia health states
and indicated a difference in the ordering of the
dementia health states by utility value across popula-
tions. The differences between patient/carer and gen-
eral population values for measure-specific full
health are surprising, given that there are no health
problems in measure-specific full health. The differ-
ence in the ordering of dementia health states was
not a logical inconsistency, as for these states, it cannot
be determined which is least severe. This is because
a given state is not consistently better across all dimen-
sions (e.g., DEMQOL-U states 32143 and 41212). How-
ever, this does suggest a difference in the valuation
and tradeoff between different dimensions by popula-
tion, suggesting that a value set estimated for patients
and carerswouldhavedifferent relativeweightings for
different dimensions. Further research is encouraged,
as although previous work has suggested that patients
and members of the general population weight prob-
lems in physical andmental health differently,16 there
may also be differences in relativeweightings between
different aspects of mental health and cognition by
population. Any difference in the relative weightings
of physical and mental health and cognition by mem-
bers of the general population and patients is impor-
tant for policy. The use of general population values
to inform policy may mean that physical health is
given a higher priority than mental health and cogni-
tion due to the higher relative weighting of physical
health states. Thismaymean that physical health con-
ditions may be prioritized at the expense of mental
health conditions including dementia. This may also
mean that mental health and cognition are given
a lower priority than patients of these conditions feel
Table 6 Regression Analysis of DEMQOL-Proxy-U Health State Values across General Population and Carer
Respondents
Model 4 Model 5 Model 6
States
1222 –0.0866a (–0.143 to –0.031) –0.050 (–0.127 to 0.027) –0.0497 (–0.126 to 0.027)
3112 –0.151a (–0.207 to –0.095) –0.114a (–0.191 to –0.037) –0.114a (–0.191 to –0.037)
1341 –0.163a (–0.219 to –0.106) –0.112a (–0.189 to –0.035) –0.112a (–0.188 to –0.035)
3234 –0.320a (–0.376 to –0.264) –0.246a (–0.323 to –0.169) –0.246a (–0.322 to –0.169)
2424 –0.335a (–0.391 to –0.279) –0.280a (–0.357 to –0.203) –0.280a (–0.357 to –0.204)
4411 –0.405a (–0.461 to –0.349) –0.338a (–0.415 to –0.261) –0.338a (–0.415 to –0.262)
4444 –0.673a (–0.729 to –0.617) –0.548a (–0.625 to –0.471) –0.548a (–0.625 to –0.471)
Carer population –0.177a (–0.250 to –0.103)
Carer interaction terms
1111 3 carer –0.061 (–0.164 to 0.043) –0.0557 (–0.162 to 0.051)
1222 3 carer –0.138a (–0.242 to –0.034) –0.130b (–0.236 to –0.023)
3112 3 carer –0.138a (–0.242 to –0.034) –0.123b (–0.229 to –0.016)
1341 3 carer –0.167a (–0.271 to –0.063) –0.150a (–0.257 to –0.044)
3234 3 carer –0.215a (–0.319 to –0.111) –0.215a (–0.321 to –0.108)
2424 3 carer –0.174a (–0.278 to –0.070) –0.168a (–0.275 to –0.062)
4411 3 carer –0.200a (–0.304 to –0.095) –0.192a (–0.299 to –0.086)
4444 3 carer –0.321a (–0.425 to –0.217) –0.325a (–0.432 to –0.219)
Constant 0.974a (0.911 to 1.037) 0.918a (0.846 to 0.990) 0.918a (0.846 to 0.990)
Observations 1184 1184 1144
Number of individuals 148 148 143
Within R2 0.478 0.483 0.450
Between R2 0.137 0.137 0.120
Overall R2 0.341 0.385 0.321
Root mean squared error 0.236 0.237 0.236
Wald x2 971.76 986.02 827.53
Notes: 95%confidence intervals are in parentheses. The reference state is 1111 valued by the general population.Model 4 includes as explanatory variables
dementia health state dummies and population. Model 5 also includes interaction terms capturing population and dementia health state effects. Model 6
has the same specification asmodel 5 and excludes 5 respondentswhose understanding of the time tradeoff taskwas doubted by the interviewers. The carer
population variable is a dummy variable for carers.
a. Significant at 1% level.
b. Significant at 5% level.
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is warranted due to their higher relativeweightings for
mental health over physical health.
Patients and carers had a higher range ofmean util-
ity values for dementia health states than the general
population. This has important implications for
cost-utility analyses, as a larger range is likely to
mean a larger change in QALYs over time or across
health interventions. In addition, the size of the dif-
ference in values between populations for a given
dementia health state is large, with coefficients for
the interaction terms between population and
dementia health states in the regression analysis
varying from –0.131 to –0.274 for patients valuing
DEMQOL-U and –0.061 to –0.321 for carers valuing
DEMQOL-Proxy-U. These differences are large, con-
sidering that for the SF-6D, a generic preference-
based measure derived from the SF-36, a minimal
important difference has been found to range from
0.010 to 0.048 with a mean effect size of 0.051.26
Recent trials in dementia, for example, the HTA-
SADD trial for the use of antidepressants for depres-
sion in dementia,27 have included DEMQOL and
DEMQOL-Proxy and have generated utility values
using DEMQOL and DEMQOL-Proxy-U.11 If these
values were used to inform resource allocation, the
use of general population values would impact the
results.
Regression analysis indicated that differences in
utility values by population were not due to differen-
ces in the observed sociodemographic characteristics
of the population. Few sociodemographic variable
coefficients were significant and had a minimal
impact on model performance and hence were not
reported. This indicates that the differences in eli-
cited utility values may be due to a range of other fac-
tors such as other unobserved differences in the
population, consideration of adaptation, response
shift, or differences in their understanding and inter-
pretation of the dementia health states.
The differences in patient and carer values and
general population values may reflect the public per-
ception in general of dementia. Dementia is a disorder
that attracts substantial stigma and that is relatively
poorly understood by the general public including
misconceptions that it is a normal part of aging and
that there is nothing that can be done to help people
with dementia.28 This lack of clarity about dementia
may drive the higher values provided by the general
population for dementia health states compared to
the values provided by those affected by dementia
who will have a clearer idea of the multiple negative
impacts of the disorder. The wording and labeling of
the classification system may also have impacted
values. Respondents from the general population
were not informed that the studywas about dementia
or that the health states were dementia specific,
whereas patients with dementia and carers knew
that the studywas about dementia andmay have real-
ized that the health states were dementia specific.
This meant that patients and carers may have had
a greater understanding of the dementia health states
and also known the underlying cause of the health
state. Thismeans that the differences in values across
the populations may have been due to the labeling
effect or due to the differences in underlying prefer-
ences across the different populations, and using
our study design, it is not possible to disentangle
these 2 effects. This can be interpreted as a weakness
of our study design. Indeed, a recent study examin-
ing the effects of including a condition label in the
description of health states valued using TTO by
members of the general population found that condi-
tion labels impacted utility values and that the
impact differed by condition label and health state
severity.29 However, we believe that it is an advan-
tage of our study that members of the general popu-
lation did not know the underlying cause of the
health state, as it is clear that there are public mis-
conceptions of cognitive impairment and dementia
(e.g., its being an inevitable part of aging) and
considerable stigma attached to dementia.28 The
use of a condition label would mean that these mis-
conceptions and stigma may have inappropriately
impacted the utility values elicited from the general
population.
One potential limitation of the study is the use of
ranking as a warm-up task for members of the general
population and no warm-up task for patients or
carers. The ranking task was included for members
of the general population in accordance with the
MVH protocol of TTO used to value the EQ-5D in
the UK but was thought too complex for the patient
population that has neuropsychological and cogni-
tive problems. The lack of awarm-up task for patients
and carers may have affected their values, as prior to
the TTO task, they had not had a chance to think
about how they would value different dementia
health states, and it may have affected their under-
standing of the TTO task. However, the rank task is
a very different task to the TTO task, and the rank
task can be seen as a way of encouraging respondents
to think about the dementia health states and how
they value them in comparison to each other. Argu-
ably, the ranking task was more important for mem-
bers of the general population who have not
experienced these or similar health states and may
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be unfamiliar with the context of the dementia health
state, whereas patients and carers have prior knowl-
edge of similar dementia health states.
Another potential limitation of this study is the
requirement of patients with dementia, who by defi-
nition have cognitive impairment, to value dementia
health states using a cognitively demanding elicita-
tion technique. Patients and carers had significantly
higher proportions of respondents (12.7% and
7.0%, respectively) than the general population
(1.3% for DEMQOL-U and 0% for DEMQOL-Proxy-
U) whowere reported by the interviewers as doubtful
that they understood the TTO task, but these propor-
tions are not especially high. The patient group was
restricted to those with dementia of a mild severity
to maximize their ability to complete the elicitation
technique. The preferred regression model specifica-
tions were also estimated using samples that
excluded respondents whose understanding of the
TTO task was doubted by the interviewers, but the
impact upon the coefficients of dementia health state
severity and interaction effects was minimal. The
MVHTTOprotocol has beenwidely used in valuation
studies of the general population but may be more
challenging for respondents with cognitive problems.
However, TTO is no more challenging than many
other iterative elicitation techniques such as standard
gamble or person tradeoff. Ranking and discrete
choice-based valuation methods are cognitively
demanding in a different way, as the tasks require
the simultaneous consideration of multiple health
states in which all of the attributes can vary between
health states and/or tasks. In addition, ordinal data
face the challenge of anchoring the values on the 1-
0 full health–dead scale (see Rowen and others30 for
an overview). Best-worst scaling is one option that
may be less cognitively demanding and that has suc-
cessfully been used in adolescents31 but requires addi-
tional data, such as TTO or standard gamble data, to
anchor the values onto the 1-0 full health–dead scale.
The study was designed to take into consideration
the health and competencies of the patient popula-
tion at every stage: the team engaged with the Alz-
heimer’s Society through its Quality Research in
Dementia panel prior to designing the study; patients
were referred to the study by clinicians specializing
in dementia; and interviewswere immediately termi-
nated if the patient suffered from fatigue, misunder-
standing, or distress during the interview. For these
reasons, the samples are composed of patients with
mild dementia and carers of patients with mild
dementia. This means that there may be limits in
the generalizability of findings to those with more
severe dementia and their carers, as we do not know
whether preferences of carers and patients with
mild dementia are representative of all carers and
patients with dementia. This was a constraint of con-
ducting a valuation study in this patient group.
Patients with dementia and carers of patients with
dementia gave systematically lower utility values for
dementia health states than members of the general
population. The differences in values were not due
to differences in the sociodemographic characteris-
tics of the populations. The ordering of utility values
for dementia health states differed across popula-
tions, suggesting a difference in the valuation
and tradeoff between different dimensions across
populations. These results suggest that the popula-
tion used to produce dementia health state utility val-
ues could impact the results of cost-utility analyses
and potentially affect resource allocation decisions.
However, at present, only general population values
are available for use to generate utility values for
cost-utility analyses. The results of this work suggest
that this may lead to higher utility values being used
in economic evaluations than patients and carers
indicate are representative of dementia health states.
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